Cargando…
Brand Name Versus Generic?
Autor principal: | Aungaroon, Gewalin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10273811/ https://www.ncbi.nlm.nih.gov/pubmed/37334417 http://dx.doi.org/10.1177/15357597231155715 |
Ejemplares similares
-
The ACTH Quandary: Balancing Efficacy and Affordability for Infantile Spasms Treatment
por: Aungaroon, Gewalin
Publicado: (2023) -
Does Deep Brain Stimulation Work in Lennox-Gastaut Syndrome? Well…it
Depends
por: Aungaroon, Gewalin
Publicado: (2022) -
A Muddy Crystal Ball for Infantile-Onset Epilepsy Outcomes
por: Aungaroon, Gewalin
Publicado: (2022) -
Generic versus brand-name drugs used in cardiovascular diseases
por: Manzoli, Lamberto, et al.
Publicado: (2015) -
Generics versus brand-named drugs for glaucoma: the debate continues
por: Bhartiya, Shibal, et al.
Publicado: (2020)